Celestica (CLS) PT Lowered to $430 at Barclays
Tweet
Share
E-mailGet Alerts CLS Hot Sheet
Price: $339.46 +9.37%
Rating Summary:
18 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
18 Buy, 9 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Barclays analyst George Wang lowered the price target on Celestica (NYSE: CLS) to $430.00 (from $441.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Sumitomo Forestry Co (1911:JP) PT Lowered to JPY1,920 at Nomura/Instinet
- Macquarie Upgrades Hankook Tire Co Ltd (161390:KS) to Outperform
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
